• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchCONTRAFECT
    Picture of CONTRAFECT logo

    CFRXQ — CONTRAFECT News Story

    $0.000.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    • Market Cap
      $0.00m
    • Enterprise Value
      -$5.41m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • CFRXQ Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    CFRXQ Dividends
    All News

    NASDAQ TRADE HALT MARKET WIDE CIRCUIT BREAKER RESUMPTION AT 08:49 AM

    Picture of CONTRAFECT logoCONTRAFECT
    09/03/2020 13:49
    NASDAQ TRADE HALT  CFRX.O  MARKET WIDE CIRCUIT BREAKER RESUMPTION AT 08:49 AM
    

    Recent news on CONTRAFECT

    See all news
    • Brief: Contrafect Corp - On Nov 7, Co Received Delisting Notification From Nasdaq Hearings Advisor Stating That Panel Determined To Delist Co's Common Stock

      08/11/2023 23:01
    • Brief: ContraFect Says Selling Securityholder May Offer And Selling Up To 7 Mln Shares In Aggregate Of Common Stock

      24/10/2023 21:53
    • Brief: Contrafect Announces FDA Clearance Of CF-370 IND Application To Proceed With Phase 1 Clinical Study

      16/10/2023 12:30
    • Brief: Contrafect Corp Says On Sept 21, Notified By Nasdaq, That Co Not In Compliance With The Minimum Bid Price Requirement

      29/09/2023 18:38
    • Brief: Contrafect Announces Submission Of Ind Application To The FDA For Its Development Candidate Cf-370

      18/09/2023 12:36

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.